Mumbai MLA hostel caterer's licence suspended after Shiv Sena leader assaults staff over ‘stale' food complaint
The contractor, Ajanta Caterers, had violated provisions of the Food Safety and Standards Act, 2006, and the Food Safety and Standards (Licensing and Registration of Food Businesses) Regulations, 2011, the FDA said in its suspension order on Wednesday.
The regulator further said that the violations were found when it conducted an inspection at the Akashwani MLA hostel on Wednesday.
Starting Thursday, Ajanta Caterers has been directed to stop serving food and cease operations at the hostel premises.
The FDA's investigation came after a viral video footage showed Buldhana MLA Sanjay Gaikwad slapping and punching an employee at the MLAs' hostel canteen for serving 'stale food'.
While the authorities launched the probe, the action received widespread condemnation from government and opposition, with Maharashtra Chief Minister Devendra Fadnavis denouncing the act.
The CM said such behaviour sends a "wrong message" about legislators misusing their power.
The Mumbai canteen viral video shows Buldhana MLA Sanjay Gaikwad, wearing a vest and a towel, confronting the canteen contractor and forcing him to smell a packet of dal before slapping and punching him.
The contractor falls on the floor due to the impact, and as he tries to get up, the MLA continues with the assault.
Gaikwad, however, remained defiant and said he doesn't regret his action.
"I will not apologise. Whatever the CM and Deputy CM said is their duty. I respect their words, but they also said that there should be an inquiry into the hotel. I have no regrets. I was about to consume poison; others cannot understand this, so I have no regrets for what I did," the Shiv Sena MLA told reporters on Wednesday.
Food and Drug Administration (FDA) officials took food samples from the Akashvani MLA canteen.
"Samples of paneer, Schezwan chutney, oil, and toor dal have been taken. These will be sent to the lab and the report will come in 14 days, an FDA official was quoted as saying by ANI.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
4 hours ago
- Indian Express
Hemp-based innovations, products unlocks Himachal's latent potential
Dr Rashmi Punhani, a qualified paediatric dentist from Arki in Solan district, who co-owns start-up Pi Hemp Pvt Ltd with her husband Anil Kumar, in Shimla, showcased a range of hemp seed-based products, including toothpaste, bamboo toothbrushes, and hemp biochar, sold from Solan. Haneesh Katnawer, a production engineer and founder of Himalayan Hemp Industries Pvt Ltd in Kandarori, Kangra, participated in the event, accompanied by his team. His enterprise displayed reusable hemp sanitary pads, handbags, and nutritional products — all manufactured in Kangra. However, it was Rohit Chauhan from Kangra who stole the spotlight. Chauhan runs Him Care Lab, manufacturing medicinal products like pain relief oil, balm and sleeping pills — all made using hemp seeds sourced locally. These entrepreneurs were among a dozen other participants from Himachal Pradesh, Uttarakhand, Maharashtra and Delhi who displayed their hemp-based innovations during the one-day event titled Seminar & Exhibition on Innovative Industrial & Medicinal Cannabis-Hemp Plant-Based Products. The event was inaugurated by Revenue and Horticulture Minister Jagat Singh Negi and concluded in the presence of Chief Minister Sukhvinder Singh Sukhu. 'I am a qualified paediatric dentist. My husband and I launched Pi Hemp Pvt Ltd in 2021 after obtaining necessary approvals from the Ministry of AYUSH,' Dr Punhani told The Indian Express. 'We use hemp seed extract to manufacture toothpaste under the brand Neti-Neti Oral Care. Our gum serum and toothbrushes, made from bamboo and coated with plant-based resin and neem oil, are designed to be eco-friendly. Initially, we wanted to use hemp oil for coating, but it was too expensive.' Dr Punhani added, 'The packaging is done in Himachal, while formulation and manufacturing take place in Raipurrani, Haryana. We collaborate with Him Care Lab for hemp oil, though only hemp seeds are FDA-approved; leaves and flowers are not permitted for use. Our research into hemp seed-based products, including biochar, was supported by IIT, Kanpur, and Pusa Krishi, Delhi.' The startup launched its toothpaste in December 2023 with a 100g pack priced at Rs 199 (Rs169 on Amazon). 'We've received a great response, particularly from Chandigarh, Delhi and Bengaluru, where I studied and spent over a decade before relocating to my hometown, Arki,' she said. Discussing their work with biochar, Dr Punhani said, 'We are exploring four raw materials: Lantana camara, pine needles, bamboo and hemp. Though we have received permission to use wild hemp for biochar production, the work is yet to begin. Many young people are interested in entering this sector, but the lack of awareness is holding them back. If we succeed, it will inspire others. We are currently operating out of Panchkula, but planning to shift our manufacturing to Himachal. We named our hemp seed-made toothpaste Neti-Neti, a term taken from Upnishadas to be taken to self-realisation.' Chauhan of Him Care Lab, a Government of India-funded venture launched in November 2021, said, 'We manufacture hemp seed-based products in Himachal Pradesh. For products made using extracts from hemp leaves and flowers, we rely on Madhya Pradesh and Uttar Pradesh, where controlled cannabis cultivation is permitted under strict guidelines.' He added, 'There are barely a dozen startups like ours in the state. The scope is currently limited due to regulatory challenges. We procure hemp seeds from Uttarakhand, which is the largest market in the country. Our products are marketed under the brand Cannarma.' Chauhan, who recently launched hemp cultivation under a joint venture in Uganda, said, 'Himachal is lagging behind because we lack a policy to regulate hemp cultivation. For quality medicinal products, we need access to raw materials like seeds, leaves and flower extracts in a controlled manner. Ironically, the quality of wild hemp in Himachal is better than Uttarakhand, MP or J&K.' Revenue and Horticulture Minister Negi, under whose purview a hemp committee has been constituted, said, 'Himachal has enormous potential for hemp-based industries. While hemp seed-based product manufacturing is permitted in many parts of the country, including Himachal, progress is hampered by the unavailability of raw materials. So far, only a handful of entrepreneurs have entered this space. We are in the process of formulating a strict policy for the controlled cultivation of hemp for industrial and medicinal use.' Haneesh Katnawer of Himalayan Hemp Industries Pvt Ltd and the Himalayan Hemp Research Foundation, both based in Kandarori, Kangra, said, 'Our goal is to preserve native Himalayan varieties by creating essential products such as reusable hemp sanitary pads, hemp houses and nutritional supplements. We've been approved for Rs 1.5 crore in funding from BIRAC and AIM under the central government, but the funds have been delayed for two years. Despite that, we became the first company to win the National Startup Award for our patented hemp sanitary pads.' 'Our reusable pads are antibacterial and rash-resistant. I believe the Himachal government should adopt them to set a positive example for other states and promote safe, eco-friendly alternatives in rural areas,' Katnawer said, adding: 'We are setting up our factory in Kandarori with sponsorship from Punjab National Bank.' Himalayan Hemp Industries Pvt Ltd won the National Startup Award 2022-23 in the construction category. During the Assembly session in September last year, the House passed a significant resolution to legalise cannabis cultivation, following the recommendations of an Assembly committee report. This decision follows the recommendations of a committee led by the Revenue Minister, who also chaired the Assembly's panel on the subject. The idea was initially brought up in the Assembly under Rule 130, with support from both ruling and opposition members. A committee was then formed to explore the feasibility of cannabis cultivation, and the resolution was passed based on the panel's findings. The committee studied the successful models in Jammu and Kashmir, Uttarakhand, and Madhya Pradesh. The overwhelming consensus was in favour of legalising it in Himachal Pradesh. Negi had highlighted the practicality of cannabis as a crop, noting it requires minimal water, is resistant to animal damage, and is largely disease-free. Industrial hemp will be drug-free, containing negligible levels of THC, while medicinal cannabis will be strictly regulated, similar to opium cultivation under the NDPS Act.
Hans India
4 hours ago
- Hans India
FSDA suspends 133 drug licences, cancels 20 in June
Bengaluru: Enforcement officers of the Karnataka Food Safety and Drug Administration department have suspended 133 drug licences and cancelled 20 drug licences in June for violations of the provisions of the Drugs and Cosmetics Act, officials said on Friday. The move was initiated after the officials concerned conducted 2,544 inspections over the last month, they said. According to the department, drug-testing laboratories in Bengaluru, Hubballi and Ballari analysed 1,333 samples in June. Among those, 1,292 samples were declared as 'Standard Quality' and 41 as 'Not of Standard Quality'. From April to June, the enforcement officers filed a total of 81 cases in courts against firms that violated the provisions of the Drugs and Cosmetics Act, 1940 and the Rules thereunder, the department said. The department has ensured that 'Not of Standard Quality' drugs worth more than Rs 40 lakh were recalled from the market and seized. A special drive was conducted across the blood centres in the state and a total of 122 such centres were inspected. Based on the various violations observed, show-cause notices were issued to 44 blood centres and compliance letters were issued to 80 blood centres,' the department said in a statement. According to the statement, in compliance with the Food Safety and Standards Act, 2006, food safety, quality and hygiene aspects were inspected across the state, covering 1,557 street-food vendors, in June. Notices were issued to 406 establishments where violations were identified and fines totalling Rs 44,500 were imposed on the spot, the statement added.
Hans India
a day ago
- Hans India
New weekly injection to offer steady Parkinson's medication, cut need for daily pills
A team of scientists in Australia, led by those of Indian origin, has developed a new once-a-week injectable drug that could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets. Frequent dosing is a burden, especially for elderly patients or those with swallowing difficulties, leading to inconsistent medication levels, more side effects, and reduced effectiveness. To address this, the team from the University of South Australia (UniSA) developed a long-acting injectable formulation that delivers a steady dose of levodopa and carbidopa -- two key medications for Parkinson's -- over an entire week. The biodegradable formulation is injected under the skin or into muscle tissue, where it gradually releases the medication over seven days, noted the researchers in the paper published in the journal Drug Delivery and Translational Research. The newly developed injectable could significantly improve treatment outcomes and patient adherence, said lead researcher Professor Sanjay Garg, from UniSA's Center for Pharmaceutical Innovation. "Our goal was to create a formulation that simplifies treatment, improves patient compliance, and maintains consistent therapeutic levels of medication. This weekly injection could be a game-changer for Parkinson's care," Garg said. "Levodopa is the gold-standard therapy for Parkinson's, but its short lifespan means it must be taken several times a day." The injectable gel combines a US FDA-approved biodegradable polymer, PLGA, with Eudragit L-100, a pH-sensitive polymer, to achieve a controlled and sustained drug release. The team noted that the release of both levodopa and carbidopa steadily over a week could help maintain consistent plasma levels and reduce the risks associated with fluctuating drug concentrations. Extensive lab tests confirmed the system's effectiveness and safety. More than 90 per cent of the levodopa dose and more than 81 per cent of the carbidopa dose were released over seven days. Notably, the implant degraded by over 80 per cent within a week and showed no significant toxicity in cell viability tests. In addition, the formulation can be easily administered through a fine 22-gauge needle, minimising discomfort and eliminating the need for surgical implantation. Garg said the technology could also be adapted for other chronic conditions such as cancer, diabetes, neurodegenerative disorders, pain management, and chronic infections that require long-term drug delivery.
